STANDSTILL AGREEMENTStandstill Agreement • June 7th, 2019 • Vertex Pharmaceuticals Inc / Ma • Pharmaceutical preparations
THIS STANDSTILL AGREEMENT (this “Agreement”) is made and entered into as of June 6, 2019 (the “Effective Date”), by and between CRISPR Therapeutics AG, a stock corporation (Aktiengesellschaft) organized under the laws of Switzerland (the “Company”), and Vertex Pharmaceuticals Incorporated (“Vertex Parent”) and Vertex Pharmaceuticals (Europe) Limited (“Vertex UK” and, together with Vertex Parent, “Vertex”). The Company, Vertex Parent and Vertex UK each may be referred to herein individually as a “Party” or collectively as the “Parties”.
